Brown Advisory Large-Cap Growth Strategy Q1 2026 Portfolio Review [Seeking Alpha]
Alnylam Pharmaceuticals, Inc. (ALNY)
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.alnylam.com/investor-overview
Company Research
Source: Seeking Alpha
Microsoft lagged during the quarter despite reporting strong underlying results, as investor focus remained on slightly softer Azure growth and elevated AI-related investment. We believe Alnylam Pharmaceuticals' differentiated platform and growing pipeline position it well for sustained long-term growth. CoStar Group was eliminated from the portfolio during the quarter as our conviction in the near-term outlook declined. Richard Drury/DigitalVision via Getty Images The following segment was excerpted from the Brown Advisory Large-Cap Growth Strategy Q1 2026 Commentary The Brown Advisory Large-Cap Growth Strategy declined during the first quarter of 2026, modestly trailing the Russell 1000® Growth Index. This article was written by Quick Insights GNRC rebounded on improving outage activity, strong Commercial & Industrial sales, and a growing data center backlog, reinforcing its long-term growth outlook in backup power solutions. Both INTU and FICO were sold due to in
Show less
Read more
Impact Snapshot
Event Time:
ALNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALNY alerts
High impacting Alnylam Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ALNY
News
- A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Choppy Trading And Rich P/E Multiple [Yahoo! Finance]Yahoo! Finance
- Alnylam to Webcast Conference Call Discussing First Quarter 2026 Financial ResultsBusiness Wire
- Aerska Strengthens Leadership and Board with Key Appointments to Advance Systemically Delivered RNA Medicines for the Brain [Yahoo! Finance]Yahoo! Finance
- RNAi?????2035??25?6,720?????????CAGR9.30%???????????????????????? : ???????????????????? [CNET News]CNET News
- Alnylam Pharmaceuticals (ALNY) had its price target lowered by Truist Financial Corporation from $515.00 to $505.00. They now have a "buy" rating on the stock.MarketBeat
ALNY
Earnings
- 2/12/26 - Beat
ALNY
Sec Filings
- 4/7/26 - Form 4
- 4/7/26 - Form 3
- 4/6/26 - Form ARS
- ALNY's page on the SEC website